Hepatitis B screening and care in Phichit Province
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial offers free hepatitis B testing and long-term monitoring for adults living in Phichit Province, Thailand, who were born before 1992. If you test positive for the hepatitis B virus, you may be invited to join a follow-up program to manage your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born before January 1, 1992
- You live in Phichit Province, Thailand
- You test positive for hepatitis B surface antigen (HBsAg)
- You are not already in care for hepatitis B (or are willing to join a follow-up program if already in care)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This study tests whether a smartphone app called HBVCare helps patients with chronic hepatitis B stick to their treatment plans. Researchers will track how well the app helps patients take their medicines on time and understand what makes treatment adherence easier or harder.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study follows adults with long-term hepatitis B to better understand their health over time and improve care. If you have chronic hepatitis B and can do regular check-ins, you may be invited to join.
This study follows patients who completed a previous trial of peginterferon alfa-2b and tenofovir for chronic hepatitis B. It checks long-term health and offers further treatment options based on your response to the earlier therapy.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.